Aprepitant bulk supplier for pharma manufacturers

Aprepitant Suppliers & Bulk Manufacturers

Available Forms: Oral capsules, Injection (IV)

Available Strengths: Capsule (80 mg, 125 mg); Injection (IV):150 mg/3 mL

Reference Brands: Emend®(US & EU)

Aprepitant 80 mg and 125 mg Capsules are essential in managing chemotherapy-induced nausea and vomiting (CINV). Available under the brand name Emend® in both oral capsule and intravenous injection (150 mg/3 mL) formulations, Aprepitant is a neurokinin-1 receptor antagonist used in combination with other antiemetic agents. Approved in both the U.S. and EU, it effectively prevents acute and delayed nausea and vomiting caused by chemotherapy treatments, particularly those with high emetogenic potential. Aprepitant plays a critical role in oncology B2B portfolios focused on supportive cancer care, improving patient quality of life during treatment.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Aprepitant 80 mg and 125 mg Capsules are essential in managing chemotherapy-induced nausea and vomiting (CINV). Available under the brand name Emend® in both oral capsule and intravenous injection (150 mg/3 mL) formulations, Aprepitant is a neurokinin-1 receptor antagonist used in combination with other antiemetic agents. Approved in both the U.S. and EU, it effectively prevents acute and delayed nausea and vomiting caused by chemotherapy treatments, particularly those with high emetogenic potential. Aprepitant plays a critical role in oncology B2B portfolios focused on supportive cancer care, improving patient quality of life during treatment.

Aprepitant — third party manufacturing & bulk supply

Aprepitant is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Aprepitant is supplied as Oral capsules, Injection (IV) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Aprepitant listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Aprepitant →

Back to Listing

Frequently Asked Questions

Aprepitant is listed as Oral capsules, Injection (IV) in Capsule (80 mg, 125 mg); Injection (IV):150 mg/3 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Aprepitant is referenced against Emend®(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.